Pharmacology and Toxicology
Showing page 15 of 22 pages of list content
-
CETSA®MS profiling for a comparative assessment of FDA approved antivirals repurposed for COVID-19 therapy identifies Trip13 as a Remdesivir off-target
This article's authors -
In VitroActivity of Itraconazole Against SARS-CoV-2
This article's authors -
The Effect of Famotidine on SARS-CoV-2 Proteases and Virus Replication
This article's authors -
The hyperlipidaemic drug fenofibrate significantly reduces infection by SARS-CoV-2 in cell culture models
This article's authors -
Interactions of anti-COVID-19 drug candidates with multispecific ABC and OATP drug transporters
This article's authors -
Ivermectin repurposing for COVID-19 therapy: Safety and pharmacokinetic assessment of a novel nasal spray formulation in a pig model
This article's authors -
Ozone exposure upregulates the expression of host susceptibility protein TMPRSS2 to SARS-CoV-2
This article's authors -
In vitroefficacy of Artemisinin-based treatments against SARS-CoV-2
This article's authors -
Platycodin D prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infectionin vitroby hindering membrane fusion
This article's authors -
Fast and scalable lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro
This article's authors